Key result
Macroalbuminuria linked to ~2-fold higher 5-year cardiovascular risk in type 2 diabetes.
Cohort (n=48,753)
Yes
Answers are grounded in this paper and cite their sources.
OBJECTIVE: To derive a 5-year cardiovascular disease (CVD) risk equation from usual-care data that is appropriate for people with type 2 diabetes from a wide range of ethnic groups, variable glycemic control, and high rates of albuminuria in New Zealand. RESEARCH DESIGN AND METHODS: This prospective open-cohort study used primary-care data from 36,127 people with type 2 diabetes without previous CVD to derive a CVD equation using Cox proportional hazards regression models. Data from 12,626 people from a geographically different area were used for validation. Outcome measure was time to first fatal or nonfatal cardiovascular event, derived from national hospitalization and mortality records. Risk factors were age at diagnosis, diabetes duration, sex, systolic blood pressure, smoking status, total cholesterol-to-HDL ratio, ethnicity, glycated hemoglobin (A1C), and urine albumin-to-creatinine ratio. RESULTS: Baseline median age was 59 years, 51% were women, 55% were of non-European ethnicity, and 33% had micro- or macroalbuminuria. Median follow-up was 3.9 years (141,169 person-years), including 10,030 individuals followed for at least 5 years. At total of 6,479 first cardiovascular events occurred during follow-up. The 5-year observed risk was 20.8% (95% CI 20.3-21.3). Risk increased with each 1% A1C (adjusted hazard ratio 1.06 [95% CI 1.05-1.08]), when macroalbuminuria was present (2.04 [1.89-2.21]), and in Indo-Asians (1.29 [1.14-1.46]) and Maori (1.23 [1.14-1.32]) compared with Europeans. The derived risk equations performed well on the validation cohort compared with other risk equations. CONCLUSIONS: Renal function, ethnicity, and glycemic control contribute significantly to cardiovascular risk prediction. Population-appropriate risk equations can be derived from routinely collected data.
No takes yet. Share an insight, caveat, or question.
Elley et al. (2010) conducted a cohort in Type 2 diabetes (n=48,753). Cardiovascular risk factors (including macroalbuminuria, A1C, and ethnicity) vs. Absence of risk factor / reference group was evaluated on Time to first fatal or nonfatal cardiovascular event (HR 2.04, 95% CI 1.89-2.21). Macroalbuminuria (HR 2.04; 95% CI 1.89-2.21) and each 1% A1C increase (HR 1.06; 95% CI 1.05-1.08) increased 5-year CVD risk (20.8% overall) in type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: